WhisperFromWallStreet's Blog

Just another WordPress.com weblog

AVNR – AVNR Declare the Enrollment of Zenvia Open Label Extension Study

leave a comment »

Avanir Pharmaceuticals, Inc, AVNR

WhisperFromWallStreet.com offers daily stock alerts to subscribers. Sign up for our free alerts newsletter.

AVANIR Pharmaceuticals, Inc. today announced that the open label extension of the confirmatory Phase III STAR trial is now fully enrolled. The primary objective of the open-label extension study is to assess the long-term safety of Zenvia in patients diagnosed with pseudobulbar affect resulting from an underlying neurological disorder. In total, 282 of 326 patients (or 86.5%) completed the 12-week double-blind phase of the study and were eligible to enroll in the open label extension phase. A total of 253 (or 89.7%) of eligible patients elected to enroll in the 12-week open label safety extension. The low overall rate of discontinuation in the blinded phase and high percentage of eligible patients choosing to enroll in the optional open label extension phase compare favorably with previous experience.

About WhisperFromWallStreet.com

WhisperfromWallStreet.com is a FREE award winning newsletter that specializes in sending alerts to our subscribers on stocks we think are going to run, why we think so, as well as teaching you how to become a better trader. We scan hundreds of stocks a day to find those that meet our criteria and when we find one, we send you an alert.

Sign up for our FREE alerts newsletter at WhisperfromWallStreet.com

Disclaimer: Full disclaimer at http://whisperfromwallstreet.com/disclaimer.php

info@WhisperfromWallStreet.com
whisperfromwallstreet.com

Reblog this post [with Zemanta]

TPI – Tianyin Pharmaceutical Co., Inc. Announces Cash Dividend to Common Stockholders

leave a comment »

Tianyin Pharmaceutical Co., Inc., TPI

WhisperFromWallStreet.com offers daily stock alerts to subscribers. Sign up for our free alerts newsletter.

Tianyin Pharmaceutical Co., Inc., a manufacturer and supplier of modernized traditional Chinese medicine (“TCM”) based in Chengdu, China, today declared a quarterly cash dividend to be paid to its common stock shareholders. The dividend of $0.025 will be paid to shareholders of record as of July 31, 2009, with the actual distribution occurring on or about September 10, 2009. In addition, Tianyin will pay the quarterly dividend on its Series A Preferred Stock in cash to holders of record as of June 30, 2009. As of July 1, 2009, there are 6,826,500 shares of Series A Preferred Stock outstanding, which are convertible into shares of Tianyin’s common stock at $1.60 per share and mature in January 2011.

Sign up for our FREE alerts newsletter at WhisperfromWallStreet.com

Disclaimer: Full disclaimer at http://whisperfromwallstreet.com/disclaimer.php

info@WhisperfromWallStreet.com
whisperfromwallstreet.com

Reblog this post [with Zemanta]

Written by wfws123

July 15, 2009 at 5:41 pm

MON – Monsanto Company Invests in Developing New Technologies for Wheat With Acquisition of WestBred Business

leave a comment »

Monsanto Co., MON

WhisperFromWallStreet.com offers daily stock alerts to subscribers.  Sign up for our free alerts newsletter.

Monsanto Company announced today it is expanding its strong seeds and traits portfolio to include wheat. The company has acquired the assets of WestBred, LLC, a Montana-based company that specializes in wheat germplasm, the crop’s seed genetic material. The investment will bolster the future growth of Monsanto’s seeds and traits platform and allow farmers to benefit from the company’s experience in drought-, disease- and pest-tolerance innovations. “The U.S. wheat industry has come together to call for new technology investment, and we believe we have game-changing technologies – like our drought-tolerance and improved-yield traits – that can meaningfully address major challenges wheat growers face every season,” said Carl Casale, executive vice president of global strategy and operations for Monsanto. “Through WestBred, we’ll be able to deliver advances in breeding and biotechnology to deliver a step-change in yield while creating a springboard for new partnerships and collaboration opportunities that create additional value for farmers.”

About WhisperFromWallStreet.com

WhisperfromWallStreet.com is a FREE award winning newsletter that specializes in sending alerts to our subscribers on stocks we think are going to run, why we think so, as well as teaching you how to become a better trader. We scan hundreds of stocks a day to find those that meet our criteria and when we find one, we send you an alert.

Sign up for our FREE alerts newsletter at WhisperfromWallStreet.com

Disclaimer: Full disclaimer at http://whisperfromwallstreet.com/disclaimer.php

info@WhisperfromWallStreet.com
whisperfromwallstreet.com

Reblog this post [with Zemanta]

Written by wfws123

July 15, 2009 at 5:39 pm

PATK – Patrick Industries Halts Operations with Hope to Sell

leave a comment »

Patrick Industries Inc., PATK

WhisperFromWallStreet.com offers daily stock alerts to subscribers.  Sign up for our free alerts newsletter.

Patrick Industries, a local manufacturer and distributor, has totally stopped its operations and hopes to possibly sell its facility. Primarily concerned with the custom lamination of panels for industrial and manufacturing housing accounts, the business relocated to New London 11 years ago from Charlotte, according to general manager William Beeker. “It’s the state of the economy,” said Beeker, when questioned about the plant’s closing. “The amount of business has gone down significantly,” he continued.

About WhisperFromWallStreet.com

WhisperfromWallStreet.com is a FREE award winning newsletter that specializes in sending alerts to our subscribers on stocks we think are going to run, why we think so, as well as teaching you how to become a better trader. We scan hundreds of stocks a day to find those that meet our criteria and when we find one, we send you an alert.

Sign up for our FREE alerts newsletter
at WhisperfromWallStreet.com

Disclaimer: Full disclaimer at http://whisperfromwallstreet.com/disclaimer.php

info@WhisperfromWallStreet.com
whisperfromwallstreet.com

Reblog this post [with Zemanta]

CSCO – Cisco Announces Workforce Retraining Initiative to Drive Innovation, Economic Growth and Job Opportunities

leave a comment »

Cisco Systems, Inc., CSCO

WhisperFromWallStreet.com offers daily stock alerts to subscribers. Sign up for our free alerts newsletter.

Cisco today launched a new Workforce Retraining Initiative (WRI) and pilot training program in Michigan that President Barack Obama lauded in a speech at the Macomb Community College in Warren, Michigan.  WRI, built on the Cisco® Networking Academy®, is designed to create new job opportunities for U.S. workers and support the country’s ability to innovate, compete and prosper.

About WhisperFromWallStreet.com

WhisperfromWallStreet.com is a FREE award winning newsletter that specializes in sending alerts to our subscribers on stocks we think are going to run, why we think so, as well as teaching you how to become a better trader. We scan hundreds of stocks a day to find those that meet our criteria and when we find one, we send you an alert.

Sign up for our FREE alerts newsletter
at WhisperfromWallStreet.com

Disclaimer: Full disclaimer at http://whisperfromwallstreet.com/disclaimer.php

info@WhisperfromWallStreet.com
whisperfromwallstreet.com

Reblog this post [with Zemanta]

Penny Stock Trading Tips Offered by Micro Cap Newsletter

leave a comment »

Whisper From Wall Street, a leading small cap stock newsletter, offers tips to subscribers on how to become a successful penny stock trader. Several opportunities of late have proven to be profitable for many traders. The penny stock market is known for producing trading opportunities that can lead to large percentage gains. However, as an investor you are going to have trades go against you; it happens to everyone. Learning to limit losses in these situations is an important lesson when learning to become a successful penny stock trader.

Written by wfws123

July 14, 2009 at 5:05 pm

Small Cap Stock Newsletter Educates Readers on Penny Stock Tradings

leave a comment »

Trading penny stocks can be both exciting and rewarding; at the same time, this market can be difficult to understand. Often traders chose to follow the advice of others or mimic the actions of successful traders. In doing so, many traders are investing as much in the quality of this advice then they are in the companies they are buying and selling. In the small cap and micro cap markets the ability to weigh the motivations of this advice can be the difference between gains and losses.

Written by wfws123

July 9, 2009 at 5:22 pm

Penny Stock Newsletter Teaches Small Cap Trading Rules

leave a comment »

At WhisperFromWallStreet, a leading financial newsletter, we strive to educate our subscribers on trading securities in the small cap and micro cap markets. When a subscriber signs up for our free newsletter they receive our “Trading Rules” email outlining some of the more important rules involved with trading penny stocks.

 

Trading smaller companies can be quite different the trading larger securities. Factors involved in fluctuation in share price are not always the same indicators as those used by investors when trading larger public companies. However, within the penny stock market some common rules apply that may help investors become successful traders. Our penny stock newsletter, WhisperfromWallStreet, aims to educate subscribers with common “Trading Rules” that can “begin to limit losses and increase profits.”

 

“Limit Your Risk” – A large part of becoming a successful penny stock trader is in learning to limit losses. Investors often believe that a company’s stock will turn around, turning a current loss into a future gain. Holding onto such investments can be costly, easily turning a 10% loss into a much greater loss. “Successful traders know how to limit losses while unsuccessful ones do not.” It is important to know when to cut your losses and move on to another investment.

 

“Getting In” – Our WhisperfromWallStreet penny stock newsletter offers advice on how to enter an investment. “Don’t chase stocks,” we wrote in our newsletter. It is important to understand that there will be another good investment “right around the corner.” If you miss your entry point it may be a good idea to wait for the next opportunity.

 

“Selling on the way up” – When entering a new trade determine beforehand where you want to get out when the stock moves up. “There is nothing wrong with taking 10%, 15%, or 20% profits on trades.” Sometimes it is more important to learn to make profitable trades then it is to try to buy at every low and sell at every high.

 

Our small cap stock newsletter offers the advice above and much more as we strive to educate our subscribers in learning to become successful penny stock traders. Our penny stock newsletter goes on to explain the importance of “Trailing Stops” and when to use market orders opposed to the right and wrong times to use limit orders. Our goal is to offer the tools and the knowledge our readers need to make sound investing decisions.

 

If you’re looking for quality information about the penny stock market or to learn more about penny stocks, the lessons offered by our WhisperfromWallStreet penny stock newsletter may be of use to you. To learn more about the WhisperfromWallStreet newsletter please visit our website at WhisperfromWallStreet.com.

 

Disclaimer: Full disclaimer at http://whisperfromwallstreet.com/disclaimer.php

 

WhisperfromWallStreet.com (WFWS) based upon information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by WFWS to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. WFWS is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.whisperfromwallstreet.com or mentioned herein. WFWS may have been compensated with shares or with cash from third party shareholders or the company on behalf of one or more of the companies mentioned in this opinion.

 

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies’ annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and WFWS undertakes no obligation to update such statements.

 

This is not a solicitation to buy or sell any securities. WhisperfromWallStreet.com, nor any of its affiliates are not registered investment advisors or a broker dealers. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.

 

CONTACT: WhisperFromWallStreet.com

Written by wfws123

July 7, 2009 at 7:35 pm

American Express Company Credit Card Craziness.

leave a comment »

American Express Company

23.09 Down 0.15 (0.65%)  2:24pm ET

Last I checked, the economy’s still in recession, unemployment is rising, and consumers are having trouble paying their bills. But you wouldn’t know this from looking at what’s going on in the credit card world lately.

ABOUT

American Express Company, a payments and travel company, provides charge and credit payment card products, and travel-related services worldwide. It operates in two groups, the Global Consumer Group and the Global Business-to-Business Group. The Global Consumer Group offers a range of products and services, including charge and credit card products, consumer travel services, and stored value products, such as Travelers Cheques and prepaid products.

Last Trade:     23.10
Day’s Range:      23.06 – 23.55
52wk Range:       9.71 – 42.50
Volume:         9,170,436

Here are a few alerts our WhisperfromWallStreet.com subscribers enjoyed.

SPNG 1000%

AMNG 241%

RKBD 300%

UTRM 169%

TLLE 266%

Sign up to receive free stock alerts

Disclaimer: Full disclaimer at http://whisperfromwallstreet.com/disclaimer.php

Reblog this post [with Zemanta]

Written by wfws123

July 1, 2009 at 8:46 pm

5 Cold Stocks Heating Up.

leave a comment »

Cell Therapeutics, Inc.,CTIC

1.69 Down 0.03 (1.74%)  2:13pm ET

When a stock’s share price is lower than a North Dakota thermometer in February, investors tend to give it the cold shoulder. But as the market warms to a stock’s prospects, that stock’s price can heat up in a hurry. Alas, you can rarely tell that a stock is melting investors’ hearts until after it’s made that upward leap.

ABOUT

Cell Therapeutics, Inc., a biopharmaceutical company, develops, acquires, and commercializes oncology products for cancer treatment. Its development portfolio includes Pixantrone, a phase III trial product, for non-Hodgkin’s lymphoma; Brostallicin, which is in first-line Phase II study for the treatment of sarcoma; and OPAXIO, a chemotherapeutic agent for the potential treatment of non-small cell lung, ovarian, and other cancers.

Last Trade:     1.69
Day’s Range:       1.68 – 1.72
52wk Range:        0.05 – 4.90
Volume:         5,760,665

<<<

Here are a few alerts our WhisperfromWallStreet.com subscribers enjoyed.

SPNG 1000%

AMNG 241%

RKBD 300%

UTRM 169%

TLLE 266%

Sign up to receive free stock alerts

Disclaimer: Full disclaimer at http://whisperfromwallstreet.com/disclaimer.php

Reblog this post [with Zemanta]
Follow

Get every new post delivered to your Inbox.